Robust demand for its heart and oncology drugs helped achieve total sales for the quarter of US$17.56 billionPublished Tue, Feb ...
Pfizer has rolled out a sweeping cost reduction programme in response to the drop in Covid-19 sales Pfizer on Tuesday ...
China has approved 19 innovative medicines — including major treatments from Eli Lilly, Pfizer, and Johnson & Johnson — for ...
Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech, a remnant from one of the pandemic’s ...
Pfizer and Novo Nordisk are locked in a high-stakes battle to acquire US obesity drug developer Metsera, sending shockwaves through ...
Pfizer raised its 2025 profit forecast for the second time this year, as ongoing cost cuts helped make up for ...
Pfizer Inc. has filed a lawsuit against Metsera Inc. and Danish drugmaker Novo Nordisk A/S, aiming to block Novo's bid ...
Pfizer on Friday (Oct 31) filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations ...
More than 1,000 women across the United States have filed lawsuits against pharmaceutical giant Pfizer, alleging that its popular contraceptive ...
President Donald Trump secured a major victory Friday as AstraZeneca agreed to lower its prescription drug prices for Medicaid—a move ...
